<p>(TheNewswire)</p>
<p>加拿大不列顛哥倫比亞省温哥華</p>
<p>–2026 年 4 月 1 日– TheNewswire - MindBio</p>
<p>Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6);</p>
<p>(OTCQB:MBQIF)（以下簡稱 “公司” 或</p>
<p>“MindBio”），是一家生物技術公司，正在商業化</p>
<p>用於藥物和酒精中毒檢測的預測技術，</p>
<p>採用語音分析和人工智能，現高興地</p>
<p>宣佈已完成之前宣佈的增資</p>
<p>非承銷私人配售（以下簡稱 “發行”），</p>
<p>總收益為 1,437,828.87 美元。</p>
<p>根據該發行，公司發行了</p>
<p>總計 2,396,381 個單位（每個單位稱為 “單位”），</p>
<p>每個單位的價格為 0.60 美元，總收益為 1,437,828.87 美元。每個單位</p>
<p>由一股公司普通股（每股稱為 “股份”）和一份</p>
<p>股份購買權證（每份稱為 “權證”）組成。每份</p>
<p>權證使持有人有權在發行結束後 36 個月內以</p>
<p>0.80 美元的價格購買額外股份，</p>
<p>在加拿大證券交易所（以下簡稱 “CSE”）的股份收盤價</p>
<p>在連續十個交易日內超過 1.00 美元的情況下，權證將提前到期。</p>
<p>公司計劃將發行的淨收益用於加速開發和部署一項專有</p>
<p>硬件和邊緣技術，以便在礦區遠程和可擴展地</p>
<p>使用 MindBio 的中毒檢測解決方案，</p>
<p>用於招聘專業人員和一般營運資金。</p>
<p>與發行完成相關，公司支付了總計</p>
<p>70,183.97 美元的現金費用，並向合格的第三方</p>
<p>發行了總計 116,973 份不可轉讓的股份購買權證（每份稱為 “尋找者權證”），</p>
<p>這些第三方向公司介紹了認購者。每份尋找者權證使持有人有權</p>
<p>在發行日期後 36 個月內以 0.80 美元的價格購買一股，</p>
<p>在 CSE 的股份收盤價在連續十個交易日內超過 1.00 美元的情況下，權證將提前到期。</p>
<p>與發行相關的所有證券</p>
<p>在適用證券法的規定下，需遵守為期</p>
<p>四個月零一天的轉售限制。</p>
<p>該發行仍需最終監管批准。</p>
<p>推廣和溝通</p>
<p>合作</p>
<p>MindBio 還宣佈已與兩家獨立服務提供商簽訂</p>
<p>協議，為公司提供推廣、溝通、市場營銷和廣告服務。</p>
<p>公司已與 Stockouse Publishing Ltd（以 The Market Link 名義運營）</p>
<p>根據廣告活動協議進行合作，並與 Investor Brand Network（“IBN”）</p>
<p>根據聯合傳播協議進行合作。這些合作的目的是</p>
<p>提高公眾對公司的認識，並擴大公司新聞和信息的傳播。兩項</p>
<p>合作均不包括市場做市服務，且在任何一項</p>
<p>合作中不會發行公司的證券作為補償。公司確認，The Market Link 和 IBN 均為</p>
<p>與公司沒有直接或間接利益關係的獨立方。根據公司所知，</p>
<p>The Market Link 和 IBN 均對公司或其證券沒有任何直接或間接的</p>
<p>利益。</p>
<p>The Market Link 的合作於 2026 年 3 月 24 日開始，</p>
<p>將持續到 2027 年 3 月 24 日。在合作期間，指定的客户經理將支持</p>
<p>活動規劃、執行和優化。服務包括訪問</p>
<p>上市平台的發行人廣告庫存、客户經理的戰略支持、活動執行和</p>
<p>績效報告。推廣活動將通過 The Market Link 選擇的出版商和投資者平台進行。The Market Link</p>
<p>將在公司私人配售結束時一次性獲得 36,750 美元的現金補償。</p>
<p>在合作中不會授予股票期權或其他基於證券的補償。</p>
<p>The Market Link 的聯繫信息如下：</p>
<p>Stockouse Publishing Ltd dba The Market Link</p>
<p>1130 - 1055 West Hastings St.</p>
<p>温哥華， BC V6E 2E9</p>
<p>電子郵件：info@themarketlink.com</p>
<p>電話：1-778-588-7012</p>
<p>IBN 的合作於 2026 年 3 月 25 日開始，</p>
<p>IBN 的聯繫信息如下：</p>
<p>Investor Brand Network</p>
<p>1108 Lavaca Street, Suite 110-IBN</p>
<p>奧斯丁， TX 78701</p>
<p>聯繫人：Dutch DeWaard</p>
<p>電子郵件：Dutch@IBN.fm</p>
<p>總辦公室電話：（512）354-7000</p>
<p>聯繫人電話：480-734-5834</p>
<p>如需更多信息，請聯繫：</p>
<p>Justin Hanka, 首席執行官</p>
<p>+61 433140886</p>
<p>justin@mindbiotherapeutics.com</p>
<p>www.mindbiotherapeutics.com</p>
<p>關於 MindBio Therapeutics Corp.</p>
<p>MindBio 是一家生物技術公司，正在商業化用於通過聲音分析檢測藥物和酒精中毒的人工智能預測技術。該人工智能預測模型利用超過 5000 萬個數據點，僅通過人聲就能以顯著的準確性預測酒精中毒。公司目前正在收集數據，以使其預測工具能夠在消費者和企業環境中用於其他類型的中毒檢測。</p>
<p>關於前瞻性聲明的警示説明：</p>
<p>本新聞稿包含適用證券法意義上的 “前瞻性聲明”，包括但不限於關於本次發行收益的預期用途的聲明，包括使用聲音和人工智能開發公司的企業平台以檢測藥物和酒精中毒，以及公司與市場鏈接和投資者品牌網絡的合作的預期持續時間、範圍和預期收益。前瞻性聲明可以通過以下詞語識別：“預期”、“打算”、“計劃”、“預算”、“相信”、“項目”、“估計”、“期望”、“安排”、“預測”、“戰略”、“未來”、“可能”、“可能會”、“將要”、“可以”、“會”、“應該”、“將” 和類似的對未來時期的引用或否定或可比術語，以及通常用於未來和條件的術語。前瞻性聲明基於提供時的假設。然而，不能保證這些假設會反映這些項目或因素的實際結果。</p>
<p>此外，存在已知和未知的風險因素，可能導致公司的實際結果和財務狀況與前瞻性聲明中所指示的顯著不同。因此，您不應依賴這些前瞻性聲明。可能導致實際結果和財務狀況與前瞻性聲明中所指示的顯著不同的重要風險因素包括但不限於：未能獲得最終監管批准；企業平台開發或部署中的技術挑戰；加拿大和澳大利亞的一般經濟、市場和商業狀況；市場波動；以及任何本新聞稿中描述的交易或事件的時間表中不可預見的延誤。所有前瞻性信息均完全受此警示聲明的限制。</p>
<p>公司不承擔修訂或更新任何此類前瞻性聲明的義務，也不承擔公開宣佈任何修訂結果以反映未來結果、事件或發展的義務，除非法律要求。</p>
<p>加拿大證券交易所及其監管服務提供者（根據加拿大證券交易所政策定義的術語）對本發佈的充分性或準確性不承擔任何責任。</p>
<p>版權 (c) 2026 TheNewswire - 保留所有權利。</p>

NBSE.ESC

BTMD

醫藥突破 ETF - ALPS

<p>MindBio Therapeutics Corp. 成功完成了一項私人配售，籌集資金 1,437,828.87 美元，發行了 2,396,381 個單位，每個單位價格為 0.60 美元。這筆資金將用於增強其醉酒檢測技術的開發。此外，公司還聘請了兩家服務提供商進行推廣和營銷服務，以提高公眾意識和投資者覆蓋面。這些合作包括現金補償，並將持續一年。所有發行的證券在四個月內受限於轉售，並待最終監管批准</p>

<p>(TheNewswire)</p>
<div class="lb-trans"><p>(TheNewswire)</p>
</div><p>Vancouver, British Columbia</p>
<div class="lb-trans"><p>加拿大不列顛哥倫比亞省温哥華</p>
</div><p>– April 1, 2026 – TheNewswire - MindBio</p>
<div class="lb-trans"><p>–2026 年 4 月 1 日– TheNewswire - MindBio</p>
</div><p>Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6);</p>
<div class="lb-trans"><p>Therapeutics Corp. (CSE: MBIO); (Frankfurt: WF6);</p>
</div><p>(OTCQB:MBQIF) (the “Company” or</p>
<div class="lb-trans"><p>(OTCQB:MBQIF)（以下簡稱 “公司” 或</p>
</div><p>“MindBio”), a biotechnology company that is commercialising</p>
<div class="lb-trans"><p>“MindBio”），是一家生物技術公司，正在商業化</p>
</div><p>prediction technologies for drug and alcohol intoxication detection</p>
<div class="lb-trans"><p>用於藥物和酒精中毒檢測的預測技術，</p>
</div><p>using speech analytics and artificial intelligence, is pleased to</p>
<div class="lb-trans"><p>採用語音分析和人工智能，現高興地</p>
</div><p>announce that it has closed its previously announced upsized</p>
<div class="lb-trans"><p>宣佈已完成之前宣佈的增資</p>
</div><p>non-brokered private placement (the “Offering”) for</p>
<div class="lb-trans"><p>非承銷私人配售（以下簡稱 “發行”），</p>
</div><p>gross proceeds of $1,437,828.87</p>
<div class="lb-trans"><p>總收益為 1,437,828.87 美元。</p>
</div><p>Pursuant to the Offering, the Company issued an</p>
<div class="lb-trans"><p>根據該發行，公司發行了</p>
</div><p>aggregate of 2,396,381 units (each, a “Unit”) at a price</p>
<div class="lb-trans"><p>總計 2,396,381 個單位（每個單位稱為 “單位”），</p>
</div><p>of $0.60 per Unit for gross proceeds of $1,437,828.87. Each Unit</p>
<div class="lb-trans"><p>每個單位的價格為 0.60 美元，總收益為 1,437,828.87 美元。每個單位</p>
</div><p>consists of one common share of the Company (each, a “Share”) and one</p>
<div class="lb-trans"><p>由一股公司普通股（每股稱為 “股份”）和一份</p>
</div><p>Share purchase warrant (each, a “Warrant”). Each</p>
<div class="lb-trans"><p>股份購買權證（每份稱為 “權證”）組成。每份</p>
</div><p>Warrant entitles the holder to acquire an additional Share at a price</p>
<div class="lb-trans"><p>權證使持有人有權在發行結束後 36 個月內以</p>
</div><p>of $0.80 for a period of thirty-six months following closing of the</p>
<div class="lb-trans"><p>0.80 美元的價格購買額外股份，</p>
</div><p>Offering, subject to accelerated expiry in the event the closing price</p>
<div class="lb-trans"><p>在加拿大證券交易所（以下簡稱 “CSE”）的股份收盤價</p>
</div><p>of the Shares on the Canadian Securities Exchange (the “CSE”) exceeds $1.00</p>
<div class="lb-trans"><p>在連續十個交易日內超過 1.00 美元的情況下，權證將提前到期。</p>
</div><p>for ten consecutive trading days.</p>
<div class="lb-trans"><p>公司計劃將發行的淨收益用於加速開發和部署一項專有</p>
</div><p>The Company intends to use the net proceeds from the</p>
<div class="lb-trans"><p>硬件和邊緣技術，以便在礦區遠程和可擴展地</p>
</div><p>Offering to accelerate the development and deployment of a proprietary</p>
<div class="lb-trans"><p>使用 MindBio 的中毒檢測解決方案，</p>
</div><p>hardware and edge technology which will enable the remote and scalable</p>
<div class="lb-trans"><p>用於招聘專業人員和一般營運資金。</p>
</div><p>use of MindBio’s intoxication detection solution at mining sites,</p>
<div class="lb-trans"><p>與發行完成相關，公司支付了總計</p>
</div><p>for recruitment of specialised personnel and for general working</p>
<div class="lb-trans"><p>70,183.97 美元的現金費用，並向合格的第三方</p>
</div><p>capital purposes.</p>
<div class="lb-trans"><p>發行了總計 116,973 份不可轉讓的股份購買權證（每份稱為 “尋找者權證”），</p>
</div><p>In connection with completion of the Offering, the</p>
<div class="lb-trans"><p>這些第三方向公司介紹了認購者。每份尋找者權證使持有人有權</p>
</div><p>Company paid aggregate cash fees of $70,183.97 and issued an aggregate</p>
<div class="lb-trans"><p>在發行日期後 36 個月內以 0.80 美元的價格購買一股，</p>
</div><p>of 116,973 non-transferable Share purchase warrants (each, a</p>
<div class="lb-trans"><p>在 CSE 的股份收盤價在連續十個交易日內超過 1.00 美元的情況下，權證將提前到期。</p>
</div><p>“Finder Warrant”) to eligible third-parties who introduced subscribers to</p>
<div class="lb-trans"><p>與發行相關的所有證券</p>
</div><p>the Offering. Each Finder Warrant entitles the holder thereof to</p>
<div class="lb-trans"><p>在適用證券法的規定下，需遵守為期</p>
</div><p>acquire one Share at a price of $0.80 for a period of thirty-six</p>
<div class="lb-trans"><p>四個月零一天的轉售限制。</p>
</div><p>months after the date of issue, subject to accelerated expiry in the</p>
<div class="lb-trans"><p>該發行仍需最終監管批准。</p>
</div><p>event the closing price of the Shares on the CSE exceeds $1.00 for ten</p>
<div class="lb-trans"><p>推廣和溝通</p>
</div><p>consecutive trading days.</p>
<div class="lb-trans"><p>合作</p>
</div><p>All securities issued in connection with the Offering</p>
<div class="lb-trans"><p>MindBio 還宣佈已與兩家獨立服務提供商簽訂</p>
</div><p>are subject to restrictions on resale for a period of</p>
<div class="lb-trans"><p>協議，為公司提供推廣、溝通、市場營銷和廣告服務。</p>
</div><p>four-months-and-one-day in accordance with applicable securities laws.</p>
<div class="lb-trans"><p>公司已與 Stockouse Publishing Ltd（以 The Market Link 名義運營）</p>
</div><p>The Offering remains subject to final regulatory approvals.</p>
<div class="lb-trans"><p>根據廣告活動協議進行合作，並與 Investor Brand Network（“IBN”）</p>
</div><p>Promotional and Communications</p>
<div class="lb-trans"><p>根據聯合傳播協議進行合作。這些合作的目的是</p>
</div><p>Engagements</p>
<div class="lb-trans"><p>提高公眾對公司的認識，並擴大公司新聞和信息的傳播。兩項</p>
</div><p>MindBio also announces that it has entered into</p>
<div class="lb-trans"><p>合作均不包括市場做市服務，且在任何一項</p>
</div><p>agreements with two arm’s length service providers to provide</p>
<div class="lb-trans"><p>合作中不會發行公司的證券作為補償。公司確認，The Market Link 和 IBN 均為</p>
</div><p>promotional, communications, marketing and advertising services to the</p>
<div class="lb-trans"><p>與公司沒有直接或間接利益關係的獨立方。根據公司所知，</p>
</div><p>Company.</p>
<div class="lb-trans"><p>The Market Link 和 IBN 均對公司或其證券沒有任何直接或間接的</p>
</div><p>The Company has engaged Stockouse Publishing Ltd dba</p>
<div class="lb-trans"><p>利益。</p>
</div><p>The Market Link (“The Market</p>
<div class="lb-trans"><p>The Market Link 的合作於 2026 年 3 月 24 日開始，</p>
</div><p>Link”) pursuant to an advertising campaign</p>
<div class="lb-trans"><p>將持續到 2027 年 3 月 24 日。在合作期間，指定的客户經理將支持</p>
</div><p>agreement and Investor Brand Network (“IBN”) pursuant to a</p>
<div class="lb-trans"><p>活動規劃、執行和優化。服務包括訪問</p>
</div><p>syndicated communications agreement. The purpose of these engagements</p>
<div class="lb-trans"><p>上市平台的發行人廣告庫存、客户經理的戰略支持、活動執行和</p>
</div><p>is to increase public awareness of the Company and broaden</p>
<div class="lb-trans"><p>績效報告。推廣活動將通過 The Market Link 選擇的出版商和投資者平台進行。The Market Link</p>
</div><p>dissemination of the Company’s news and information. Neither</p>
<div class="lb-trans"><p>將在公司私人配售結束時一次性獲得 36,750 美元的現金補償。</p>
</div><p>engagement includes market making services, and no securities of the</p>
<div class="lb-trans"><p>在合作中不會授予股票期權或其他基於證券的補償。</p>
</div><p>Company will be issued as compensation in connection with either</p>
<div class="lb-trans"><p>The Market Link 的聯繫信息如下：</p>
</div><p>engagement. The Company confirms that both The Market Link and IBN are</p>
<div class="lb-trans"><p>Stockouse Publishing Ltd dba The Market Link</p>
</div><p>arm’s length parties to the Company. To the knowledge of the</p>
<div class="lb-trans"><p>1130 - 1055 West Hastings St.</p>
</div><p>Company, neither The Market Link nor IBN has any direct or indirect</p>
<div class="lb-trans"><p>温哥華， BC V6E 2E9</p>
</div><p>interest in the Company or its securities.</p>
<div class="lb-trans"><p>電子郵件：info@themarketlink.com</p>
</div><p>The Market Link engagement commenced on March 24, 2026</p>
<div class="lb-trans"><p>電話：1-778-588-7012</p>
</div><p>and will continue until March 24, 2027. Under the engagement, an</p>
<div class="lb-trans"><p>IBN 的合作於 2026 年 3 月 25 日開始，</p>
</div><p>assigned account manager will support campaign planning, execution and</p>
<div class="lb-trans"><p>IBN 的聯繫信息如下：</p>
</div><p>optimization throughout the program term. Services include access to</p>
<div class="lb-trans"><p>Investor Brand Network</p>
</div><p>issuer advertising inventory across listed platforms, strategic</p>
<div class="lb-trans"><p>1108 Lavaca Street, Suite 110-IBN</p>
</div><p>support from an account manager, campaign execution, and performance</p>
<div class="lb-trans"><p>奧斯丁， TX 78701</p>
</div><p>reporting. The promotional activity will occur through The Market</p>
<div class="lb-trans"><p>聯繫人：Dutch DeWaard</p>
</div><p>Link’s selected publishers and investor platforms. The Market Link</p>
<div class="lb-trans"><p>電子郵件：Dutch@IBN.fm</p>
</div><p>will receive cash compensation of $36,750 payable upfront upon closing</p>
<div class="lb-trans"><p>總辦公室電話：（512）354-7000</p>
</div><p>of the Company’s private placement. No stock</p>
<div class="lb-trans"><p>聯繫人電話：480-734-5834</p>
</div><p>options or other securities-based compensation will be granted in</p>
<div class="lb-trans"><p>如需更多信息，請聯繫：</p>
</div><p>connection with the engagement.</p>
<div class="lb-trans"><p>Justin Hanka, 首席執行官</p>
</div><p>The Market Link contact details are as follows:</p>
<div class="lb-trans"><p>+61 433140886</p>
</div><p>Stockouse Publishing Ltd dba The Market Link</p>
<div class="lb-trans"><p>justin@mindbiotherapeutics.com</p>
</div><p>1130 - 1055 West Hastings St.</p>
<div class="lb-trans"><p>www.mindbiotherapeutics.com</p>
</div><p>Vancouver, BC V6E 2E9</p>
<div class="lb-trans"><p>關於 MindBio Therapeutics Corp.</p>
</div><p>Email: info@themarketlink.com</p>
<p>Telephone: 1-778-588-7012</p>
<p>The IBN engagement commenced on March 25, 2026 and willcontinue until March 25, 2027. Under the engagement, IBN will providean investor awareness and media exposure program intended to increasethe Company’s market visibility and broaden investor reach. Servicesinclude ongoing content distribution such as articles, newsletterfeatures, press release amplification and recap coverage acrossIBN’s media, syndication and social channels. The engagement alsoincludes promotional support through interviews, social mediarelations, and access to IBN’s partner network and consultingexperience. The promotional activity will occur through InvestorWire,InvestorNewsBreaks, IBN newsletters, IBN’s social media network,podcast directories including Apple Podcasts, Spotify and iHeartRadio,and broader syndication channels. IBN will receive cash compensationof $34,847.50 per quarter for a 12-month term, for aggregatecompensation of $139,390. No stock options or other securities-basedcompensation will be granted in connection with the engagement.</p>
<p>The IBN contact details are as follows:</p>
<p>Investor Brand Network</p>
<p>1108 Lavaca Street, Suite 110-IBN</p>
<p>Austin, TX 78701</p>
<p>Contact : Dutch DeWaard</p>
<p>Email: Dutch@IBN.fm</p>
<p>General Office Telephone: (512) 354-7000</p>
<p>Contact Telephone: 480-734-5834</p>
<p>For further information, please contact:</p>
<p>Justin Hanka, Chief ExecutiveOfficer</p>
<p>+61 433140886</p>
<p>justin@mindbiotherapeutics.com</p>
<p>www.mindbiotherapeutics.com</p>
<p>About MindBio TherapeuticsCorp.</p>
<p>MindBio is a biotechnologycompany that is commercialising AI prediction technologies for drugand alcohol intoxication detection via voice analysis. The AIprediction model uses over 50 million data points to predict alcoholintoxication with remarkable accuracy, just by using the human voice.The Company is now collecting data that will allow its prediction toolto work on other types of intoxication for use in consumer andenterprise environments.</p>
<div class="lb-trans"><p>MindBio 是一家生物技術公司，正在商業化用於通過聲音分析檢測藥物和酒精中毒的人工智能預測技術。該人工智能預測模型利用超過 5000 萬個數據點，僅通過人聲就能以顯著的準確性預測酒精中毒。公司目前正在收集數據，以使其預測工具能夠在消費者和企業環境中用於其他類型的中毒檢測。</p>
</div><p>Cautionary Note ConcerningForward-Looking Statements:</p>
<div class="lb-trans"><p>關於前瞻性聲明的警示説明：</p>
</div><p>The press release contains “forward-lookingstatements” within the meaning of applicable securities laws,including but not limited to, statements regarding the intended use ofproceeds from the Offering, including the development of theCompany’s enterprise platform using voice and powered by AI for usein detecting drug and alcohol intoxication, and the expected duration,scope and anticipated benefits of the Company’s engagements with TheMarket Link and Investor Brand Network. Forward-looking statements canbe identified by words such as: “anticipate,” “intend,”“plan,” “budget,” “believe,” “project,”“estimate,” “expect,” “scheduled,”“forecast,” “strategy,” “future,” “likely,” “may,”“to be,” “could,” “would,” “should,” “will” andsimilar references to future periods or the negative or comparableterminology, as well as terms usually used in the future andconditional. Forward-looking statements are based on assumptions as ofthe date they are provided. However, there can be no assurance thatsuch assumptions will reflect the actual outcome of such items orfactors.</p>
<div class="lb-trans"><p>本新聞稿包含適用證券法意義上的 “前瞻性聲明”，包括但不限於關於本次發行收益的預期用途的聲明，包括使用聲音和人工智能開發公司的企業平台以檢測藥物和酒精中毒，以及公司與市場鏈接和投資者品牌網絡的合作的預期持續時間、範圍和預期收益。前瞻性聲明可以通過以下詞語識別：“預期”、“打算”、“計劃”、“預算”、“相信”、“項目”、“估計”、“期望”、“安排”、“預測”、“戰略”、“未來”、“可能”、“可能會”、“將要”、“可以”、“會”、“應該”、“將” 和類似的對未來時期的引用或否定或可比術語，以及通常用於未來和條件的術語。前瞻性聲明基於提供時的假設。然而，不能保證這些假設會反映這些項目或因素的實際結果。</p>
</div><p>Additionally, there are known and unknown risk factorsthat could cause the Company’s actual results and financialconditions to differ materially from those indicated in theforward-looking statements. Therefore, you should not rely on any ofthese forward-looking statements. Important risk factors that couldcause actual results and financial conditions to differ materiallyfrom those indicated in the forward-looking statements, include amongothers: the failure to obtain the final regulatory approval; technicalchallenges in the development or deployment of its enterpriseplatform; general economic, market and businessconditions in Canada and Australia; market volatility; and unforeseendelays in timelines for any of the transactions or events described inthis press release. All forward-looking information is qualified inits entirety by this cautionary statement.</p>
<div class="lb-trans"><p>此外，存在已知和未知的風險因素，可能導致公司的實際結果和財務狀況與前瞻性聲明中所指示的顯著不同。因此，您不應依賴這些前瞻性聲明。可能導致實際結果和財務狀況與前瞻性聲明中所指示的顯著不同的重要風險因素包括但不限於：未能獲得最終監管批准；企業平台開發或部署中的技術挑戰；加拿大和澳大利亞的一般經濟、市場和商業狀況；市場波動；以及任何本新聞稿中描述的交易或事件的時間表中不可預見的延誤。所有前瞻性信息均完全受此警示聲明的限制。</p>
</div><p>The Company disclaims any obligation to revise orupdate any such forward-looking statement or to publicly announce theresult of any revisions to any of the forward-looking informationcontained herein to reflect future results, events or developments,except as required by law.</p>
<div class="lb-trans"><p>公司不承擔修訂或更新任何此類前瞻性聲明的義務，也不承擔公開宣佈任何修訂結果以反映未來結果、事件或發展的義務，除非法律要求。</p>
</div><p>Neither the Canadian Securities Exchange nor itsRegulation Service Provider (as that term is defined in the policiesof the Canadian Securities Exchange) accepts responsibility for theadequacy or accuracy of this release.</p>
<div class="lb-trans"><p>加拿大證券交易所及其監管服務提供者（根據加拿大證券交易所政策定義的術語）對本發佈的充分性或準確性不承擔任何責任。</p>
</div><p>Copyright (c) 2026 TheNewswire - All rights reserved.</p>
<div class="lb-trans"><p>版權 (c) 2026 TheNewswire - 保留所有權利。</p>
</div>

MindBio 宣佈完成私募配售